Clinical Trials Search at Vanderbilt-Ingram Cancer Center

The RADIANCE-HTN; Study A study of the ReCor Medical Paradise System in Clinical Hypertension

Disease Sites: Not Available

Phase: III

Investigator: Fong, Pete

NCTID: NCT02649426

Protocol No: CRE-INT0001

EARLY TAVR

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT03042104

Protocol No: VALV0003

CSPOT - Conduction System Pacing Optimized Therapy

Disease Sites: Not Available

Phase:

Investigator: Richardson, Travis

NCTID: NCT04905290

Protocol No: CRE-ARR0007

CLASP II TR

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT04097145

Protocol No: VALV0004

REPAIR MR

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT04198870

Protocol No: VALV0007

ADVANTAGE-AF - A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT05443594

Protocol No: CRE-ARR0017

A Phase 3, Multi-Center, Randomized, Double-blind Trial to Evaluate the
Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive
Hypertrophic Cardiomyopathy” and identified as CY 6032

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID: NCT05767346

Protocol No: CRE-CHF0015

CY 6031 A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CK3773274 IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID: NCT05186818

Protocol No: CRE-CHF0007

The FARAPULSE ADVENT Trial

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT04612244

Protocol No: CRE-ARR0009

A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of VGA039 Following Intravenous or Subcutaneous Administration of Single Ascending Doses in Healthy Adults and
Adult Patients with von Willebrand Disease

Disease Sites: Not Available

Phase: I

Investigator: Wheeler, Allison

NCTID: NCT05776069

Protocol No: NCBH2304-VEGA

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form